Skip to Content

Teniposide Pregnancy and Breastfeeding Warnings

Teniposide is also known as: Vumon

Teniposide Pregnancy Warnings

Teniposide has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of embryotoxicity, teratogenicity reduced sperm count and genetic damage to sperm.. There are no controlled data in human pregnancy. Teniposide should only be given during pregnancy when there are no alternatives and benefit outweighs risk. Women of childbearing potential should be advised to avoid becoming pregnant during therapy with teniposide. Young men of reproductive age should be advised of the possibility of compromised ability to father a child and a possibility for birth defects if they do. They should also be advised of the option to store sperm for future artificial insemination.

See references

Teniposide Breastfeeding Warnings

There are no data on the excretion of teniposide into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Vumon (teniposide)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Vumon (teniposide)." Bristol-Myers Squibb, Princeton, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.